(Q34447491)

2 August 2017

title

Sparteine oxidation polymorphism: a family study (English)

1 reference

2 August 2017

Brøsen K

1

1 reference

2 August 2017

Otton SV

series ordinal

2

1 reference

2 August 2017

Gram LF

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

6

1 reference

2 August 2017

page(s)

661-667

1 reference

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400985

Sparteine metabolism in Canadian Caucasians

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400985

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400985

Defective metabolism of metoprolol in poor hydroxylators of debrisoquine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400985

Sparteine oxidation polymorphism in Denmark.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400985

Defective N-oxidation of sparteine in man: A new pharmacogenetic defect

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400985

The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB05231.X

Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB05231.X

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB05231.X

E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3741716

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative pharmacogenetics of sparteine and debrisoquine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3741716

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/3741716

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1986.TB05231.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference